Abstract
Great interest exists in standardizing treatment for patients with distal deep vein thrombosis (DDVT), especially regarding the choice of anticoagulant. We evaluated the outcomes for patients with DDVT treated with warfarin vs a direct oral anticoagulant (DOAC) drug (rivaroxaban, apixaban, edoxaban, or dabigatran).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have